FDA-approval in Multiple Myeloma

Pfizer Oncology is proud to announce the FDA approval of ELREXFIO™ (elranatamab-bcmm). The following information is available for State Society review: 

Full Prescribing Information Including Boxed Warning and Medication Guide 

If you have any questions, please contact me at your earliest convenience. If you prefer not to receive emails like this one, please let me know and I will not send them to you in the future.